Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms

Yaël Zermati(Hôpital Necker-Enfants Malades), Paulo De Sepulveda(Inserm), Frédéric Féger(Hôpital Necker-Enfants Malades), Sébastien Letard(Inserm), Joëlle Kersual(Hôpital Necker-Enfants Malades), Nathalie Castéran(Inserm), Guy Gorochov(Inserm), Michel Dy(Hôpital Necker-Enfants Malades), Antoni Ribadeau Dumas(Hôpital Necker-Enfants Malades), Karim Dorgham(Inserm), Christophe Parizot(Inserm), Yann Bieche(Université Paris Cité), Michel Vidaud(Inserm), Olivier Lortholary(Hôpital Avicenne), Michel Arock(Hôpital Necker-Enfants Malades), Olivier Hermine(Hôpital Necker-Enfants Malades), Patrice Dubreuil(Inserm)
Oncogene
February 5, 2003
Cited by 188

Abstract


Related Papers

No related papers found

Powered by citation graph analysis